Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $680,229.

  • Molecular Partners Ag's Cash from Financing Activities rose 4.10% to $680,229 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 1380.74%. This contributed to the annual value of $16.4 million for FY2024, which is 1362.60% up from last year.
  • Per Molecular Partners Ag's latest filing, its Cash from Financing Activities stood at $680,229 for Q3 2025, which was up 203.39% from -$657,935 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Cash from Financing Activities peaked at $57.0 million during Q2 2021, and registered a low of -$56.6 million during Q3 2021.
  • Over the past 3 years, Molecular Partners Ag's median Cash from Financing Activities value was -$335.90 (recorded in 2025), while the average stood at $1.4 million.
  • In the last 5 years, Molecular Partners Ag's Cash from Financing Activities plummeted by 523.64% in 2023 and then surged by 1,353.31% in 2024.
  • Over the past 5 years, Molecular Partners Ag's Cash from Financing Activities (Quarterly) stood at $54.8 million in 2021, then crashed by 102.97% to -$1.6 million in 2022, then rose by 19.27% to -$1.3 million in 2023, then skyrocketed by 1,353.31% to $16.5 million in 2024, then climbed by 4.10% to $680,229 in 2025.
  • Its Cash from Financing Activities stands at $680,229 for Q3 2025, versus -$657,935 for Q2 2025 and -$335.90 for Q1 2025.